SecuritySPRWF / Supreme Pharmaceuticals, Inc. (868632100)
IndustryCannabis and Medical Marijuana Dispensaries
Institutional Owners1
Institutional Shares200

Institutional Stock Ownership and Shareholders

SPRWF / Supreme Pharmaceuticals, Inc. Institutional Ownership

Supreme Pharmaceuticals, Inc. (OTC:SPRWF) has 1 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 200 shares. Largest shareholders include Vantage Investment Advisors, LLC.
Supreme Pharmaceuticals, Inc. (OTC:SPRWF) ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds more than 5% of the company and intends to actively pursue a change in business strategy. Schedule 13G indicates a passive investment of over 5%. Green rows indicate new positions. Red rows indicate closed positions. Click the link icon to see the full transaction history.

File DateFormInvestor Opt Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
($1000)
Current Value
($1000)
Change
(Percent)
2018-08-13 13F-HR Vantage Investment Advisors, LLC 200 200 0.00 0 0
SPRWF: Supreme Pharmaceuticals (CNSX:SL) Analysis and Research Report

2017-12-22 - Asif

Supreme Pharmaceuticals is a federally incorporated Canadian company. Supreme is focused on developing cannabis-focused businesses in the emerging global cannabis market. Management believes cannabis represents one of the world's most exciting emerging industries. Cannabis is consumed globally but in most countries consumption is still illegal. Recently, international jurisdictions have been re-evaluating their respective cannabis policies and legislation as part of a growing trend towards the legalization of medical cannabis and, in some cases, recreational cannabis. Canada first legalized cannabis for medical purposes in 2001 with the creation of the Marihuana Medical Access Regulations (the "MMAR"). In 2013, the MMAR was replaced by the Marihuana for Medical Purposes Regulations (the "MMPR"). The MMPR created a federally legal and regulated framework for commercial cultivation, distribution and sale of medical cannabis by licensed entities (a "Licensed Producer"). In 2016 the MMP...

CUSIP: 868632100